A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Clinical trial NCT07171606 · RECRUITING

Trial details

NCT number: NCT07171606
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

First-line Advanced NSCLC Patients

Start date: 2025-10-24
Primary completion: 2026-08-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.